 | Up a level |
Koziolek, M., Beige, J., Wallbach, M., Zenker, D., Henning, G., Halbach, M., Mader, N., Mahfoud, F., Schlieper, G., Schwenger, V., Hausberg, M., Boergel, J., Lodde, M., van der Giet, M., Mueller-Ehmsen, J., Passauer, J., Parmentier, S., Lueders, S., Kraemer, B. K., Buettner, S., Limbourg, F., Jordan, J., Vonend, O., Predel, H. -G. and Reuter, H. (2017). Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection. Recommendations of the BAT consensus group 2017. Internist, 58 (10). S. 1114 - 1124. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Taubert, M., Ebert, N., Martus, P., van der Giet, M., Fuhr, U. and Schaeffner, E. (2020). Simplification and validation of a three-compartment model of iohexol to estimate plasma clearance in patients with impaired kidney function. Naunyn-Schmiedebergs Arch. Pharmacol., 393 (SUPPL 1). S. 79 - 80. NEW YORK: SPRINGER. ISSN 1432-1912